THE EFFECT OF A HYDROPHILIZING SUBSTANCE ON THE PROPERTIES OF THERMOSENSITIVE HYDROPHILIC GELS CONTAINING LACTIC ACID COMPLEXED WITH CHITOSAN

• Authors: Katarzyna Małolepsza-Jarmołowska
• Languages of publication: EN

Abstracts

EN

Commonly applied drug forms tend to leave the vagina when the patient assumes an upright position. Permanent contact of the drug form with the vaginal mucosa during daily activities of the patient is an indispensable condition for 24-hour therapy. This condition may be fulfilled by drug forms with high ability to adhere to vaginal mucosa. The investigations demonstrated that the thermosensitive polymer - poloxamer 407 increases significantly the adhesive properties of hydrophilic gels, but at the same time it increases their pH. The use of pectin resulted in a decrease of the pH. The addition of glycerol or 1,2-propylene glycol caused further decrease of the pH. Rheological investigations demonstrated positive pharmaceutical properties of the investigated preparations. The obtained parameters gels should provide positive application effects. The investigations revealed that it is possible to obtain gels with high adhesion properties to vaginal mucous membrane.

Keywords

EN

anti-inflammatory drugs.; hydrophilic gels; lactic acid complexed with chitosan; pectin; thermosensitive polymer-poloxamer 407; vaginal infections

• Publisher: Sieć Badawcza Łukasiewicz - Polskie Towarzystwo Chitynowe
• Journal: Progress on Chemistry and Application of Chitin and its Derivatives
• Year: 2011
• Volume: 16
• Pages: 105 - 110

Contributors

author

Katarzyna Małolepsza-Jarmołowska

• Faculty of Pharmacy The “Silesian Piasts” memorial Medical University of Wroclaw

References

• Denney JM, Culhane JF; (2009) Bacterial vaginosis: A problematic infection from both a perinatal and neonatal perspective. Sem. Fet. & Neonat. Med. Vol. 14, pp. 200-203.
• Brandt M., Abels C., May T., Lohmann K., Schmidts – Winkler I., Hoyme U. B.; (2008) Intravaginally applied metronidazole is as effective as orally applied in the treatment of bacterial vaginosis, but exhibits significantly less side effects. Eur. J. Obstet. Gynecol. Reprod. Biol. Vol. 141, pp. 158-162.
• Donders G. G. G., Larson P. G., Platz-Christensen J. J., Hallen A., Meijden W., Wölner-Hanssen P.; (2009) Variability in diagnosis of clue cells, lactobacillary grading and white blood cells in vaginal wet smears with conventional bright light and phase contrast microscopy. Eur. J. Obstet. Gynecol. Reprod. Biol. Vol. 145, pp. 109-112.
• Kubis A. A., Małolepsza-Jarmołowska K.; (1996) Studies on gynecological hydrophiling preparations comprising lactic acid. Part 1: Effects of lactic acid and hydrophiling agents on physical and chemical properties of methylcellulose gels. Pharmazie Vol. 51, pp. 989-990.
• Małolepsza-Jarmołowska K,, Kubis A. A.; (1999) Studies on gynecological hydrophilic lactic acid preparations. Part 2: Effects of Eudragit® E-100 on properties of methylcellulose gels. Pharmaziev Vol. 54, pp. 441-443.
• Małolepsza-Jarmołowska K., Kubis A. A.; (2000) Studies on gynaecological hydrophilic lactic acid preparations. Part 3: Effects of chitosan on the properties of methylcellulose gels. Pharmazie Vol. 55, pp. 610-611.
• Małolepsza-Jarmołowska K., Kubis A. A.; (2001) Studies on gynaecological hydrophilic lactic acid preparations. Part 4: Effects of polyvinyl pyrrolidone K-90 on properties of methylcellulose gels. Pharmazie Vol. 56, pp. 160-162.
• Małolepsza-Jarmołowska K., Kubis A. A., Hirnle L.; (2003) Studies on gynaecological hydrophilic lactic acid preparations. Part 5: The use of Eudragit® E-100 as lactic acid carrier in intravaginal tablets. Pharmazie Vol. 58, pp. 260-262.
• Małolepsza-Jarmołowska K., Kubis A. A., Hirnle L.; (2003) Studies on gynaecological hydrophilic lactic acid preparations. Part 6: Use of Eudragit® E-100 as lactic acid carrier in intravaginal tablets. Pharmazie Vol. 58, pp. 334-336.
• Małolepsza-Jarmołowska K.; (2006) Studies on gynaecological hydrophilic lactic acid preparations. Part 7: Use of chitosan as lactic acid carrier in intravaginal tablets (globuli vaginales). Pharmazie Vol. 61, pp. 780 - 782.
• Małolepsza-Jarmołowska K.; (2007) Studies on gynaecological hydrophilic lactic acid preparations. Part 8: Use of chitosan as lactic acid carrier in intravaginal tablets. Acta Pol. Pharm. Vol. 64, pp. 69-72.
• Małolepsza-Jarmołowska K.; (2010) The effect of poloxamer 407 on the properties of hydrophilic gels containing lactic acid complexed with chitosan. Progress on Chemistry and Application of Chitin and Its Derivatives, Vol. XV pp. 143-148.

• Document Type: article